EV/EBITDA:
35.15-0.43(-1.21%)Summary
- As of today (September 14, 2025), AKBA EV/EBITDA is 35.15, with a fall of -0.43 (-1.21%) during the most recent trading session on September 12, 2025.
- Over the past year, AKBA EV/EBITDA has dropped by -112.03 (-76.12%).
- AKBA EV/EBITDA is now -97.84% below its all-time high of 1630.17.
Performance
AKBA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKBA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -1.2% | -1.2% | -1.3% |
1 m1 month | -10.3% | -10.3% | -11.1% |
3 m3 months | -17.1% | -17.1% | -19.2% |
6 m6 months | +151.2% | +42.9% | +52.9% |
ytdytd | +153.7% | +50.1% | +55.3% |
1 y1 year | -76.1% | +132.5% | +104.9% |
5 y5 years | +4786.7% | +393.7% | +16.6% |
AKBA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 39.18 | -10.3% | 34.93 | +0.6% |
3 m | 3-month | 46.35 | -24.2% | 34.93 | +0.6% |
6 m | 6-month | 83.69 | -58.0% | -93.39 | +137.6% |
1 y | 1-year | 219.81 | -84.0% | -93.39 | +137.6% |
3 y | 3-year | 1630.17 | -97.8% | -93.39 | +137.6% |
5 y | 5-year | 1630.17 | -97.8% | -93.39 | +137.6% |
alltime | all time | 1630.17 | -97.8% | -93.39 | +137.6% |
AKBA EV/EBITDA History
Date | Value |
---|---|
2025 | 35.15(-153.7%) |
2024 | -65.42(+90.8%) |
2023 | -34.29(+560.7%) |
2022 | -5.19(+162.1%) |
2021 | -1.98(+65.0%) |
2020 | -1.20(-59.2%) |
Date | Value |
---|---|
2019 | -2.94(+52.3%) |
2018 | -1.93(-62.4%) |
2017 | -5.13(+393.3%) |
2016 | -1.04(-75.4%) |
2015 | -4.22(+23.8%) |
2014 | -3.41 |
FAQ
- What is Akebia Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Akebia Therapeutics, Inc.?
- What is AKBA EV/EBITDA year-to-date change?
- What is Akebia Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Akebia Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AKBA is 35.15
What is the all time high EV/EBITDA for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high EV/EBITDA is 1630.17
What is AKBA EV/EBITDA year-to-date change?
Akebia Therapeutics, Inc. EV/EBITDA has changed by +100.57 (+153.73%) since the beginning of the year
What is Akebia Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AKBA EV/EBITDA has changed by -112.03 (-76.12%)